AAAAAA

   
Results: 1-14 |
Results: 14
REACTIVE OXYGEN SPECIES ACTIVITY AND LIPID-PEROXIDATION IN HELICOBACTER-PYLORI-ASSOCIATED GASTRITIS - RELATION TO GASTRIC-MUCOSAL ASCORBIC-ACID CONCENTRATIONS AND EFFECT OF HELICOBACTER-PYLORI ERADICATION
Authors: DRAKE IM MAPSTONE NP SCHORAH CJ WHITE KLM CHALMERS DM DIXON MF AXON ATR
Citation: Im. Drake et al., REACTIVE OXYGEN SPECIES ACTIVITY AND LIPID-PEROXIDATION IN HELICOBACTER-PYLORI-ASSOCIATED GASTRITIS - RELATION TO GASTRIC-MUCOSAL ASCORBIC-ACID CONCENTRATIONS AND EFFECT OF HELICOBACTER-PYLORI ERADICATION, Gut, 42(6), 1998, pp. 768-771
ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (CA2) PRODUCES ENDOSCOPIC HEALING IN PATIENTS WITH TREATMENT-RESISTANT, ACTIVE CROHNS-DISEASE
Authors: DHAENS GR VANDEVENTER SJH VANHOGEZAND R CHALMERS DM BRAAKMAN TAJ SCHAIBLE TF RUTGEERTS PJ
Citation: Gr. Dhaens et al., ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (CA2) PRODUCES ENDOSCOPIC HEALING IN PATIENTS WITH TREATMENT-RESISTANT, ACTIVE CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 3951-3951
DO PATIENTS NEED TO FAST FOR A C-13-UREA BREATH TEST
Authors: MOAYYEDI P BRAUNHOLTZ D HEMINBROUGH E CLOUGH M TOMPKINS DS MAPSTONE NP MASON S DOWELL AC RICHARDS IDG CHALMERS DM AXON AT
Citation: P. Moayyedi et al., DO PATIENTS NEED TO FAST FOR A C-13-UREA BREATH TEST, European journal of gastroenterology & hepatology, 9(3), 1997, pp. 275-277
PATIENT FACTORS THAT PREDICT FAILURE OF OMEPRAZOLE, CLARITHROMYCIN, AND TINIDAZOLE TO ERADICATE HELICOBACTER-PYLORI
Authors: MOAYYEDI P CHALMERS DM AXON ATR
Citation: P. Moayyedi et al., PATIENT FACTORS THAT PREDICT FAILURE OF OMEPRAZOLE, CLARITHROMYCIN, AND TINIDAZOLE TO ERADICATE HELICOBACTER-PYLORI, Journal of gastroenterology, 32(1), 1997, pp. 24-27
ACCURACY OF THE HELISAL RAPID BLOOD KIT AND ITS USE IN PRE-ENDOSCOPICSCREENING
Authors: MOAYYEDI P NEVILLE P CLOUGH M MAPSTONE N TOMPKINS DS CHALMERS DM AXON ATR
Citation: P. Moayyedi et al., ACCURACY OF THE HELISAL RAPID BLOOD KIT AND ITS USE IN PRE-ENDOSCOPICSCREENING, Gut, 41, 1997, pp. 83-83
THE OPTIMUM 5-DAY THERAPY AGAINST HELICOBACTER-PYLORI
Authors: MOAYYEDI P LANGWORTHY H TOMPKINS DS MAPSTONE N CHALMERS DM AXON ATR
Citation: P. Moayyedi et al., THE OPTIMUM 5-DAY THERAPY AGAINST HELICOBACTER-PYLORI, Gut, 40, 1997, pp. 18-18
TREATMENT OF REFRACTORY INFLAMMATORY BOWEL-DISEASE WITH GRANULOCYTE APHERESIS
Authors: REMBACKEN BJ NEWBOULD HE DIXON MF BURY RS HENDRIKSE M CHALMERS DM
Citation: Bj. Rembacken et al., TREATMENT OF REFRACTORY INFLAMMATORY BOWEL-DISEASE WITH GRANULOCYTE APHERESIS, Gut, 40, 1997, pp. 87-87
THE OPTIMUM 5 DAY THERAPY AGAINST HELICOBACTER-PYLORI
Authors: MOAYYEDI P LANGWORTHY H TOMPKINS DS MAPSTONE N CHALMERS DM AXON ATR
Citation: P. Moayyedi et al., THE OPTIMUM 5 DAY THERAPY AGAINST HELICOBACTER-PYLORI, Gastroenterology, 112(4), 1997, pp. 223-223
MECHANISM OF ACTION OF GRANULOCYTE APHERESIS
Authors: REMBACKEN BJ NEWBOULD HE RICHARDS SJ MISBAH SA DIXON MF HENDRIKSE M CHALMERS DM AXON ATR
Citation: Bj. Rembacken et al., MECHANISM OF ACTION OF GRANULOCYTE APHERESIS, Gastroenterology, 112(4), 1997, pp. 1071-1071
TREATMENT OF REFRACTORY INFLAMMATORY BOWEL-DISEASE WITH GRANULOCYTE APHERESIS
Authors: REMBACKEN BJ NEWBOULD HE DIXON MF BURY RS HENDRIKSE M CHALMERS DM AXON ATR
Citation: Bj. Rembacken et al., TREATMENT OF REFRACTORY INFLAMMATORY BOWEL-DISEASE WITH GRANULOCYTE APHERESIS, Gastroenterology, 112(4), 1997, pp. 1071-1071
ASCORBIC-ACID MAY PROTECT AGAINST HUMAN GASTRIC-CANCER BY SCAVENGING MUCOSAL OXYGEN RADICALS
Authors: DRAKE IM DAVIES MJ MAPSTONE NP DIXON MF SCHORAH CJ WHITE KLM CHALMERS DM AXON ATR
Citation: Im. Drake et al., ASCORBIC-ACID MAY PROTECT AGAINST HUMAN GASTRIC-CANCER BY SCAVENGING MUCOSAL OXYGEN RADICALS, Carcinogenesis, 17(3), 1996, pp. 559-562
HELICOBACTER-PYLORI INFECTION AND DENTAL-CARE
Authors: HARDO PG TUGNAIT A HASSAN F LYNCH DAF WEST AP MAPSTONE NP QUIRKE P CHALMERS DM KOWOLIK MJ AXON ATR
Citation: Pg. Hardo et al., HELICOBACTER-PYLORI INFECTION AND DENTAL-CARE, Gut, 37(1), 1995, pp. 44-46
HOSPITAL PATIENTS - ARE THEY ACTIVE ENOUGH
Authors: HARDO PG CHALMERS DM AXON A
Citation: Pg. Hardo et al., HOSPITAL PATIENTS - ARE THEY ACTIVE ENOUGH, Postgraduate medical journal, 69(817), 1993, pp. 895-895
MANAGEMENT OF NSAIDS-RELATED DYSPEPSIA IN THE COMMUNITY
Authors: HARDO PG CHALMERS DM JAKEWAYS M WRIGHT V AXON ATR
Citation: Pg. Hardo et al., MANAGEMENT OF NSAIDS-RELATED DYSPEPSIA IN THE COMMUNITY, British journal of clinical practice, 47(5), 1993, pp. 241-242
Risultati: 1-14 |